Lv6
1660 积分 2021-03-26 加入
[2024 Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis]
18天前
已完结
SHR-A1811, a novel HER2-targeting antibody-drug conjugate, in advanced solid tumors (HORIZON-X): a global phase 1 trial
22天前
已完结
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
22天前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
23天前
已完结
Anti-Drug Antibody Incidence Comparison of Therapeutic Proteins Administered Via Subcutaneous vs. Intravenous Route
1个月前
已完结
Teprotumumab associated menstrual changes
1个月前
已完结
From cell line development to the formulated drug product: The art of manufacturing therapeutic monoclonal antibodies
1个月前
已完结
Incidence of Anti-Drug Antibodies to Monoclonal Antibodies in Asthma: A Systematic Review and Meta-Analysis
1个月前
已完结
Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye Disease
1个月前
已完结
皖公网安备34019202002308
